<DOC>
	<DOCNO>NCT03011294</DOCNO>
	<brief_summary>Obstructive sleep apnea ( OSA ) common clinical condition associate negative impact limit patient also partner sleep bed . Is reasonable speculate partner suffer sleep deprivation , increase level irritability , insomnia , fatigue , among others due loud snoring cause OSA patient . Although previous data report impaired sleep quality partner patient OSA , clear literature whether OSA promote cardiovascular impact treatment OSA promote cardiovascular benefit ( ) partner beyond improvement subjective objective sleep . Thus , main objective randomize control study : evaluate impact three month randomization ( treatment nasal CPAP nasal strip ) endothelial function , blood pressure ( ambulatory blood pressure monitoring ) , sleep duration ( wrist actigraphy 1 week ) sleep quality ( Pittsburgh Questionnaire ) frequency OSA bed partner patient moderate severe OSA recent diagnosis Metabolic Syndrome ( MetS ) accord ATP III criterion derive ongoing randomize study conduct Institution .</brief_summary>
	<brief_title>Cardiovascular Impact , Quality e Quantity Sleep Bed Partners Patients With Obstructive Sleep Apnea</brief_title>
	<detailed_description />
	<mesh_term>Apnea</mesh_term>
	<mesh_term>Sleep Apnea Syndromes</mesh_term>
	<mesh_term>Sleep Apnea , Obstructive</mesh_term>
	<criteria>Bed partner patient moderate severe OSA go participate ongoing randomize study Bed partner OSA use specific treatment .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2016</verification_date>
</DOC>